Healthcare, economics and society – unlocking...

Send us Fan MailHow will Most Favored Nation (MFN) pricing reshape global pharmaceutical strategy? What do emerging Centers for Medicare & Medicaid Service (CMS) models such as GENEROUS, GLOBE, and GUARD mean for launch planning, pricing corridors, and payer expectations worldwid ...  عرض المزيد

Send us Fan MailHow do LATAM healthcare markets differ and what do these differences mean for Pharma and Medtech launch planning? What should global market access teams know to support affiliates in Argentina, Brazil, Colombia, and Mexico? How do evidence requirements, access rou ...  عرض المزيد

Tune in as PwC specialists discuss the 2025 healthcare outlook, reflecting on 2024’s significant events and exploring how payers and providers can navigate rising costs, scrutiny, AI advances, and policy shifts with resilience and adaptability. Topics include:Medicare and Medicai ...  عرض المزيد

Send a text message to the show!Healthcare professionals are key players in medicines safety but they often lack the time or knowledge to report adverse drug reactions. To change that, we need to urgently rethink how we teach pharmacovigilance, argues Michael Reumerman from Amste ...  عرض المزيد

In this insightful episode, we sit down with Maysaa Jaafar, President of the Lebanese Society for Quality and Safety in Healthcare (LSQSH), to explore the remarkable journey of the society since its inception.

Maysaa shares the story behind the establishment of LSQSH, s ...

Description:In this episode, we explore the impact of software development methodologies in the medical device industry. With industry experts from HTD Health, we dissect the Agile approach to compliance, the intricacies of Quality Management Systems (such as Greenlight Guru), an ...  عرض المزيد